Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer

Stopped Suspended due to data issues revealed at DSMB meeting. Planned amendment but was never submitted. Study was then closed.

Conditions

• Non-Small Cell Lung Cancer and Pleural Mesothelioma

Interventions

• DRUG: PTK787 and Pemetrexed with or without Cisplatin

Sponsor

Nevada Cancer Institute